Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (71)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hammons, G. J.
Right arrow Articles by Kadlubar, F. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammons, G. J.
Right arrow Articles by Kadlubar, F. F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 18, 851-854, Copyright © 1997 by Oxford University Press

ARTICLES

Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes

GJ Hammons, D Milton, K Stepps, FP Guengerich, RH Tukey and FF Kadlubar
National Center for Toxicology Research, Jefferson, AR 72079, USA.

The N-hydroxylation of carcinogenic arylamines represents an initial step in their metabolic activation. Animal studies have shown that this reaction is catalyzed by the cytochrome P450 (P450) enzymes P450 1A1 and P450 1A2. In this study, utilizing enzymes expressed in Escherichia coli (and purified) or in human B-lymphoblastoid cells, the catalytic activities of recombinant human P450 1A1, P450 1A2, and P450 3A4 for N- hydroxylation of several carcinogenic arylamines were determined. P450 1A2 from both expression systems catalyzed the N-hydroxylation of 4- aminobiphenyl and the heterocyclic amines, 2-amino-3-methylimidazo[4,5- f/quinoline (IQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Rates were similar, with values of 1.1-7.8 nmol/min/nmol P450. In contrast, P450 1A1 catalyzed N-hydroxylation of only PhIP, and no activity was observed with P450 3A4. Further kinetic analysis with purified P450 1A2 showed similar Km and Vmax values for N-hydroxylation of the arylamines. Furafylline and fluvoxamine, inhibitors of P450 1A2 activity in human liver microsomes, were found to be inhibitory of the recombinant P450 1A2 N-hydroxylation activity. Results from this study are supportive of a major role for human P450 1A2 in the metabolic activation of arylamines.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. Cotterchio, B. A. Boucher, M. Manno, S. Gallinger, A. B. Okey, and P. A. Harper
Red Meat Intake, Doneness, Polymorphisms in Genes that Encode Carcinogen-Metabolizing Enzymes, and Colorectal Cancer Risk
Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3098 - 3107.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
J.-F. Han, X.-Y. He, J. S. Herrington, L. A. White, J.-F. Zhang, and J.-Y. Hong
Metabolism of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by Human CYP1B1 Genetic Variants
Drug Metab. Dispos., April 1, 2008; 36(4): 745 - 752.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
T. Fukami, M. Nakajima, H. Sakai, M. Katoh, and T. Yokoi
CYP2A13 Metabolizes the Substrates of Human CYP1A2, Phenacetin, and Theophylline
Drug Metab. Dispos., March 1, 2007; 35(3): 335 - 339.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
X. Ma, J. R. Idle, M. A. Malfatti, K. W. Krausz, D. W. Nebert, C.-S. Chen, J. S. Felton, D. J. Waxman, and F. J. Gonzalez
Mouse lung CYP1A1 catalyzes the metabolic activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)
Carcinogenesis, March 1, 2007; 28(3): 732 - 737.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. N. Lauber, S. Ali, and N. J. Gooderham
The cooked food derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine is a potent oestrogen: a mechanistic basis for its tissue-specific carcinogenicity
Carcinogenesis, December 1, 2004; 25(12): 2509 - 2517.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
M C Cornelis, A El-Sohemy, and H Campos
Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction
J. Med. Genet., October 1, 2004; 41(10): 758 - 762.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
Y. Tsuneoka, T. P. Dalton, M. L. Miller, C. D. Clay, H. G. Shertzer, G. Talaska, M. Medvedovic, and D. W. Nebert
4-Aminobiphenyl-Induced Liver and Urinary Bladder DNA Adduct Formation in Cyp1a2(-/-) and Cyp1a2(+/+) Mice
J Natl Cancer Inst, August 20, 2003; 95(16): 1227 - 1237.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
C. A. McQueen and B. Chau
Neonatal Ontogeny of Murine Arylamine N-Acetyltransferases: Implications for Arylamine Genotoxicity
Toxicol. Sci., June 1, 2003; 73(2): 279 - 286.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
J. Liu, S. S. Ericksen, D. Besspiata, C. W. Fisher, and G. D. Szklarz
Characterization of Substrate Binding to Cytochrome P450 1A1 Using Molecular Modeling and Kinetic Analyses: Case of Residue 382
Drug Metab. Dispos., April 1, 2003; 31(4): 412 - 420.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
E. I. Salim, H. Wanibuchi, K. Morimura, T. Murai, S. Makino, T. Nomura, and S. Fukushima
Induction of tumors in the colon and liver of the immunodeficient (SCID) mouse by 2-amino-3-methylimidazo[4,5-f ]quinoline (IQ)--modulation by long-chain fatty acids
Carcinogenesis, September 1, 2002; 23(9): 1519 - 1529.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
I.-L. Steffensen, H. A. J. Schut, J. E. Paulsen, A. Andreassen, and J. Alexander
Intestinal Tumorigenesis in Multiple Intestinal Neoplasia Mice Induced by the Food Mutagen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: Perinatal Susceptibility, Regional Variation, and Correlation with DNA Adducts
Cancer Res., December 1, 2001; 61(24): 8689 - 8696.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C. Chen, S. Ricks, D. R. Doody, E.D. Fitzgibbons, P. L. Porter, and S. M. Schwartz
N-Acetyltransferase 2 polymorphisms, cigarette smoking and alcohol consumption, and oral squamous cell cancer risk
Carcinogenesis, December 1, 2001; 22(12): 1993 - 1999.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M.-F. Yueh, N. Nguyen, M. Famourzadeh, C. P. Strassburg, Y. Oda, F.P. Guengerich, and R. H. Tukey
The contribution of UDP-glucuronosyltransferase 1A9 on CYP1A2-mediated genotoxicity by aromatic and heterocyclic amines
Carcinogenesis, June 1, 2001; 22(6): 943 - 950.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
C. L. Miranda, Y.-H. Yang, M. C. Henderson, J. F. Stevens, G. Santana-Rios, M. L. Deinzer, and D. R. Buhler
Prenylflavonoids from Hops Inhibit the Metabolic Activation of the Carcinogenic Heterocyclic Amine 2-Amino-3-methylimidazo[4,5-f]quinoline, Mediated by cDNA-Expressed Human CYP1A2
Drug Metab. Dispos., November 1, 2000; 28(11): 1297 - 1302.
[Abstract] [Full Text]

Home page
 Physiol. Rev.Home page
M. Wyss and R. Kaddurah-Daouk
Creatine and Creatinine Metabolism
Physiol Rev, July 1, 2000; 80(3): 1107 - 1213.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
J.-d. Huang, W.-C. Guo, M.-D. Lai, Y. L. Guo, and G. H. Lambert
Detection of a Novel Cytochrome P-450 1A2 polymorphism (F21L) in Chinese
Drug Metab. Dispos., January 1, 1999; 27(1): 98 - 101.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.